PIA
ACOR

Piedmont Investment Advisors’s Acorda Therapeutics ACOR Stock Holding History

Piedmont Investment Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-84
Closed -$134K – 1313
2019
Q1 		$134K Buy
+84
New +$151K 0.01% 1110
2018
Q3 		– Sell
-91
Closed -$313K – 2495
2018
Q2 		$313K Buy
91
+7
+8% +$21.4K 0.02% 623
2018
Q1 		$237K Buy
84
+4
+5% +$12K 0.01% 651
2017
Q4 		$206K Sell
80
-5
-6% -$14.2K ﹤0.01% 703
2017
Q3 		$240K Buy
85
+1
+1% +$2.63K 0.01% 661
2017
Q2 		$199K Buy
+84
New +$166K ﹤0.01% 708

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Piedmont Investment Advisors's ACOR Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Acorda Therapeutics (ACOR) in Q2 2019, closing a stake of 84 shares — an estimated $134K sold.

Piedmont Investment Advisors first reported a position in ACOR in Q2 2017 and held it in 6 quarters. The position peaked at $313K in Q2 2018. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining Acorda Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 84 Acorda Therapeutics shares in Q2 2019, an estimated $134K.
  • Piedmont Investment Advisors first reported a position in Acorda Therapeutics in Q2 2017 and held it in 6 quarters.
  • Piedmont Investment Advisors's Acorda Therapeutics position peaked at $313K in Q2 2018.
  • 163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.